Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE

PR Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Follow us on Google News Follow us on Google News

No Reported Serious Adverse Events; Topline Results Expected Later This Year

TREVOSE, Pa., Aug. 31, 2022 /PRNewswire/ -- Lannett Company, Inc. (NYSE:LCI) today announced that subject dosing has been completed in the pivotal clinical trial of biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies (HEC). No serious adverse events have thus far been reported.

Read more at prnewswire.com

Related Symbols

Symbol Last Chg %Chg
LCI 0.6855 +0.0255 +3.86%
Lannett Company Inc

Most Popular News

Robinhood app on phone by Andrew Neel via Unsplash 1
Huge, Unusual Put Action in Robinhood Stock - A Sign That HOOD Has Bottomed?
Stock exchange financial or forex graph by Bigc Studio via Shutterstock 2
Stock Index Futures Rally on Prospect of End to Middle East Conflict, U.S. Economic Data and Fed Speak in Focus
Image of Cathie Wood via Wikimedia Commons 3
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
Nvidia logo by Konstantin Savusia via Shutterstock 4
Nvidia (NVDA) Stock’s Discount Could Get Even More Attractive for Patient Speculators
Wheat, corn, & soybeans by Alf Ribeiro via Shutterstock 5
What Should We Expect From USDA Tuesday?
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.